Search

Acute Ischemic Stroke (AIS) is defined as the acute condition of occlusion of a cerebral artery and is often caused by a Hypertensive Condition (HC). Due to its sudden occurrence, AIS is not observable the right moment it occurs, thus information about instantaneous changes in hemodynamics is limited. This study aimed to propose an integrated Lumped Parameter (LP) model of the cardiovascular system to simulate an AIS and describe instantaneous changes in hemodynamics. In the integrated LP model of the cardiovascular system, heart chambers have been modelled with elastance systems with controlled pressure inputs; heart valves have been modelled with static open/closed pressure-controlled valves; eventually, the vasculature has been modelled with resistor-inductor-capacitor (RLC) direct circuits and have been linked to the rest of the system through a series connection. After simulating physiological conditions, HC has been simulated by changing pressure inputs and constant RLC parameters. Then, AIS occurring in arteries of different sizes have been simulated by considering time-dependent RLC parameters due to the elimination from the model of the occluding artery; instantaneous changes in hemodynamics have been evaluated by Systemic Arteriolar Flow (Qa) and Systemic Arteriolar Pressure (Pa) drop with respect to those measured in HC. Occlusion of arteries of different sizes leaded to an average Qa drop of 0.38 ml/s per cardiac cycle (with minimum and maximum values of 0.04 ml/s and 1.93 ml/s) and average Pa drop of 0.39 mmHg, (with minimum and maximum values of 0.04 mmHg and 1.98 mmHg). In conclusion, hemodynamic variations due to AIS are very small with respect to HC. A direct relation between the inverse of the length of the artery in which the occlusion occurs and the hemodynamic variations has been highlighted; this may allow to link the severity of AIS to the length of the interested artery.

Cardiotocography (CTG) is the most popular prenatal diagnostic test for establishing fetal health and consists in simultaneous recording of fetal heart rate (FHR, bpm) and maternal uterine contraction (UC, mmHg) traces. Typically, FHR and UC traces are visually analyzed and interpreted by clinicians. Recently, software applications like CTG Analyzer have been developed to support visual CTG interpretation by making it more objective and independent from clinician’s experience. Automatic CTG analysis requires CTG-traces digitalization and thus assessment of a correct sampling frequency (SF). Thus, this paper aims to investigate dependency of automatic CTG analysis on SF in order to identify optimal SF (OSF) for FHR and UC traces that minimizes computational efforts without jeopardizing CTG interpretation. To this aim, the “CTU-CHB intra-partum CTG database” was considered and visually annotated by an expert gynecologist. FHR and UC traces, originally sampled at 4 Hz, were down sampled at 2 Hz, 1 Hz, 0.4 Hz and 0.2 Hz, and automatically analyzed using CTG Analyzer. Eventually, results obtained through automatic analysis were compared to visual annotations, which were taken as reference. A cumulative statistical index (CSI), ranging from 0.00% to 100.00%, was defined as a linear combination of positive-predictive value, sensitivity, false-positive rate and false-negative rate. OSF was defined as the one that maximizes CSI. If CSI was showing the same value for more than one SF, the lowest SF was selected as the optimal since minimizing computational efforts. Results indicate that OSF for FHR is 2 Hz (CSI ≥ 85.41%), whereas OSF for UC is 0.2 Hz (CSI = 75.21%).

Electrocardiographic alternans, consisting of P-wave alternans (PWA), QRS-complex alternans (QRSA) and Twave alternans (TWA), is an index of cardiac risk. However, only automated TWA measurement methods have been proposed so far. Here, we presented the enhanced adaptive matched filter (EAMF) method and tested its reliability in both simulated and experimental conditions. Our methodological novelty consists in the introduction of a signal enhancement procedure according to which all sections of the electrocardiogram (ECG) but the wave of interest are set to baseline, and in the extraction of the alternans area (AAr) in addition to the standard alternans amplitude (AAm). Simulated data consisted of 27 simulated ECGs representing all combinations of PWA, QRSA and TWA of low (10 mu V) and high (100 mu V) amplitude. Experimental data consisted of exercise 12-lead ECGs from 266 heart failure patients with an implanted cardioverter defibrillator for primary prevention. EAMF was able to accurately identify and measure all kinds of simulated alternans (absolute maximum error equal to 2%). Moreover, different alternans kinds were simultaneously present in the experimental data and EAMF was able to identify and measure all of them (AAr: 545 mu V x ms, 762 mu V x ms and 1382 mu V x ms; AAm: 5 mu V, 9 mu V and 7 mu V; for PWA, QRSA and TWA, respectively) and to discriminate TWA as the prevalent one (with the highest AAr). EAMF accurately identifies and measures all kinds of electrocardiographic alternans. EAMF may support determination of incremental clinical utility of PWA and QRSA with respect to TWA only.

Myocardial bridge (MB) is a congenital heart condition in which a “bridge” of myocardium is overlying a “tunneled” coronary artery. MB can be associated with a series of critical cardiac events. Aim of this study was to evaluate electrocardiographic alternans (ECGA) on a MB patient, being ECGA a cardiac electrical risk index defined as beat-to-beat alternation of electrocardiographic P-wave, QRS-complex and T-wave morphology at stable heart rate. ECGA analysis was performed in a 1-hour 12-lead electrocardiographic recording of a 54 years-old MB male patient at rest by application of the heart-rate adaptive match filter method. Areas of P-wave, QRS and T-wave alternans (PWAA, QRSAA, TWAA) were measured, evaluating also the prevalent among the three. Results showed the prevalent alternans was T-wave alternans, being TWAA on average equal to 6.3 µV×s (PWAA=4.7 µV×s, QRSAA=4.3 µV×s); TWAA prevalence occurrence rate was 94% (PWAA: 5%, QRSAA:1%). TWAA was also found to be significantly correlated (p=0.72, p

Beat classification and denoising are two challenging and fundamental operations when processing digital electrocardiograms (ECG). This paper proposes the extended segmented beat modulation method (ESBMM) as a tool for automatic beat classification and ECG denoising. ESBMM includes four main steps: (1) beat identification and segmentation into PQRS and TU segments, (2) wavelet-based time-frequency feature extraction, (3) convolutional neural network-based classification to discriminate among normal (N), supraventricular (S), and ventricular (V) beats, and (4) a template-based denoising procedure. ESBMM was tested using the MIT&ndash, BIH arrhythmia database available at Physionet. Overall, the classification accuracy was 91.5% while the positive predictive values were 92.8%, 95.6%, and 83.6%, for N, S, and V classes, respectively. The signal-to-noise ratio improvement after filtering was between 0.15 dB and 2.66 dB, with a median value equal to 0.99 dB, which is significantly higher than 0 (p &lt, 0.05). Thus, ESBMM proved to be a reliable tool to classify cardiac beats into N, S, and V classes and to denoise ECG tracings.

Atrial fibrillation (AF) is a common cardiac disorder that can cause severe complications. AF diagnosis is typically based on the electrocardiogram (ECG) evaluation in hospitals or in clinical facilities. The aim of the present work is to propose a new artificial neural network for reliable AF identification in ECGs acquired through portable devices. A supervised fully connected artificial neural network (RSL_ANN), receiving 19 ECG features (11 morphological, 4 on F waves and 4 on heart-rate variability (HRV)) in input and discriminating between AF and non-AF classes in output, was created using the repeated structuring and learning (RSL) procedure. RSL_ANN was created and tested on 8028 (training: 4493, validation: 1125, testing: 2410) annotated ECGs belonging to the &ldquo, AF Classification from a Short Single Lead ECG Recording&rdquo, database and acquired with the portable KARDIA device by AliveCor. RSL_ANN performance was evaluated in terms of area under the curve (AUC) and confidence intervals (CIs) of the received operating characteristic. RSL_ANN performance was very good and very similar in training, validation and testing datasets. AUC was 91.1% (CI: 89.1%&ndash, 93.0%), 90.2% (CI: 86.2%&ndash, 94.3%) and 90.8% (CI: 88.1%&ndash, 93.5%) for the training, validation and testing datasets, respectively. Thus, RSL_ANN is a promising tool for reliable identification of AF in ECGs acquired by portable devices.

Background and objective Cardiotocography (CTG), consisting in the simultaneous recording of fetal heart rate (FHR) and maternal uterine contractions (UC), is a popular clinical test to assess fetal health status. Typically, CTG machines provide paper reports that are visually interpreted by clinicians. Consequently, visual CTG interpretation depends on clinician's experience and has a poor reproducibility. The lack of databases containing digital CTG signals has limited number and importance of retrospective studies finalized to set up procedures for automatic CTG analysis that could contrast visual CTG interpretation subjectivity. In order to help overcoming this problem, this study proposes an electronic procedure, termed eCTG, to extract digital CTG signals from digital CTG images, possibly obtainable by scanning paper CTG reports. Methods eCTG was specifically designed to extract digital CTG signals from digital CTG images. It includes four main steps: pre-processing, Otsu's global thresholding, signal extraction and signal calibration. Its validation was performed by means of the “CTU-UHB Intrapartum Cardiotocography Database” by Physionet, that contains digital signals of 552 CTG recordings. Using MATLAB, each signal was plotted and saved as a digital image that was then submitted to eCTG. Digital CTG signals extracted by eCTG were eventually compared to corresponding signals directly available in the database. Comparison occurred in terms of signal similarity (evaluated by the correlation coefficient ρ, and the mean signal error MSE) and clinical features (including FHR baseline and variability; number, amplitude and duration of tachycardia, bradycardia, acceleration and deceleration episodes; number of early, variable, late and prolonged decelerations; and UC number, amplitude, duration and period). Results The value of ρ between eCTG and reference signals was 0.85 (P Conclusions eCTG procedure is a promising useful tool to accurately extract digital FHR and UC signals from digital CTG images.

Background: Indirect fetal electrocardiography is preferable to direct fetal electrocardiography because of being noninvasive and is applicable also during the end of pregnancy, besides labor. Still, the former is strongly affected by noise so that even R-peak detection (which is essential for fetal heart-rate evaluations and subsequent processing procedures) is challenging. Some fetal studies have applied the Pan-Tompkins’ algorithm that, however, was originally designed for adult applications. Thus, this work evaluated the Pan-Tompkins’ algorithm suitability for fetal applications, and proposed fetal adjustments and optimizations to improve it. Method: Both Pan-Tompkins’ algorithm and its improved version were applied to the “Abdominal and Direct Fetal Electrocardiogram Database” and to the “Noninvasive Fetal Electrocardiography Database” of Physionet. R-peak detection accuracy was quantified by computation of positive-predictive value, sensitivity and F1 score. Results: When applied to “Abdominal and Direct Fetal Electrocardiogram Database”, the accuracy of the improved fetal Pan-Tompkins’ algorithm was significantly higher than the standard (positive-predictive value: 0.94 vs. 0.79; sensitivity: 0.95 vs. 0.80; F1 score: 0.94 vs. 0.79; Pvs. 0.55, Pvs. 0.46, P=0.23; F1 score: 0.60 vs. 0.47, P=0.11). Conclusion: In indirect fetal electrocardiographic applications, improved fetal Pan-Tompkins’ algorithm is to be preferred over the standard, since it provides higher R-peak detection accuracy for heart-rate evaluations and subsequent processing.

Currently used 24-hour electrocardiogram (ECG) monitors have been shown to skip detecting arrhythmias that may not occur frequently or during standardized ECG test. Hence, online ECG processing and wearable sensing applications have been becoming increasingly popular in the past few years to solve a continuous and long-term ECG monitoring problem. With the increase in the usage of online platforms and wearable devices, there arises a need for increased storage capacity to store and transmit lengthy ECG recordings, offline and over the cloud for continuous monitoring by clinicians. In this work, a discrete cosine transform (DCT) compressed segmented beat modulation method (SBMM) is proposed and its applicability in case of ambulatory ECG monitoring is tested using Massachusetts Institute of Technology–Beth Israel Deaconess Medical Center (MIT–BIH) ECG Compression Test Database containing Holter tape normal sinus rhythm ECG recordings. The method is evaluated using signal-to-noise (SNR) and compression ratio (CR) considering varying levels of signal energy in the reconstructed ECG signal. For denoising, an average SNR of 4.56 dB was achieved representing an average overall decline of 1.68 dBs (37.9%) as compared to the uncompressed signal processing while 95 % of signal energy is intact and quantized at 6 bits for signal storage (CR=2) compared to the original 12 bits, hence resulting in 50% reduction in storage size.

Dofetilide is an antiarrhythmic drug that selectively inhibits the rapid component of the delayed rectifier potassium current. The administration of dofetilide may cause ventricular arrhythmias and torsade de pointes. Electrocardiographic (ECG) microvolt T-wave alternans (TWA), an electrophysiologic phenomenon consisting in the beat-to-beat alternation of the T-wave amplitude requiring computerized algorithms to be detected, has also been associated to malignant ventricular arrhythmias. Aim of the present study was to evaluate if dofetilide induces TWA during the 24 hours following administration. The study population consisted of 22 healthy subjects ("ECG Effects of Ranolazine, Dofetilide, Verapamil, and Quinidine in Healthy Subjects" database by Physionet) to whom a 500 μg-dose of dofetilide was administered. For each subject, 10 s ECG were acquired at baseline (0.5 hour before dofetilide administration) and at 15 time points during the 24 hours following the drug administration. ECG were then processed for automatic TWA detection by correlation method. In 21 subjects out of 22, after dofetilide administration, TWA significantly increased to a peak value (median TWA values went from 6 μV at baseline to a max 32 μV; p; 0.05), on average after 5 hours, to then come back to values closer to baseline. Thus, in healthy subjects, dofetilide increases occurrence and levels (6 times baseline value on average) of TWA in the hours following its administration.

In preterm infants, bradycardias associate to critical health conditions. Standard algorithm for bradycardia identification assumes baseline heart rate (BHR) equal to 150bpm and identifies bradycardias when heart rate (HR) decreases below 100bpm. Since preterm infants show BHR varying from 120bpm to 160bpm, a new adaptive algorithm for real-time bradycardia identification was presented. The adaptive algorithm continuously adjusts BHR by averaging HR over the preceding 10-minute window after eliminating out-of-range HR values, and identifies bradycardias when HR decreases below 67% of BHR. Both standard and adaptive algorithms were evaluated using long-term (20.3–70.3h) electrocardiographic recordings of ten preterm infants ("Preterm Infant Cardio-respiratory Signals" database by Physionet). Bradycardias were characterized in terms of rate (BR, h−1) and depth (BD, bpm). Being also indexes of infants’ health conditions, gestational age at birth (GA, days), birth weight (BW, kg) and HR were used to evaluate performances of the algorithms. Association between BR and BD vs GA, BW and HR was evaluated by computation of the correlation coefficient (ρ). Overall, standard and adaptive algorithms identified 516 and 546 bradycardias, respectively; median BR and BD values were comparable (1.25h−1 and 76bpm vs 1.26h−1 and 70bpm, respectively). However, the adaptive algorithm provided higher BD for HR>150bpm, and vice versa. Significant (p value

Clinical utility of an electrocardiogram (ECG) affected by too high levels of noise such as baseline wanders, electrode motion artifacts, muscular artifacts and power-line interference may be jeopardized if not opportunely processed. Template-based techniques have been proposed for ECG estimation from noisy recordings, but usually they do not reproduce physiological ECG variability, which, however, provides clinically useful information on the patient's health. Thus, this study proposes the Segmented-Beat Modulation Method (SBMM) as a new template-based filtering procedure able to reproduce ECG variability, and assesses SBMM robustness to the aforementioned noises in comparison to a standard template method (STM). SBMM performs a unique ECG segmentation into QRS segment and TUP segment, and successively modulates/demodulates (by stretching or compressing) the former segments in order to adaptively adjust each estimated beat to its original morphology and duration. Consequently, SBMM estimates ECG with significantly lower estimation errors than STM when applied to recordings affected by various levels of the considered noises (SBMM: 176-232µV and 79-499µV; STM: 215-496µV and 93-1056µV, for QRS and TUP segments, respectively). Thus, SBMM is able to reproduce ECG variability and is more robust to noise than STM.

Fetal phonocardiogram (FPCG) consists in the recording of fetal heart sounds by means of a sensor placed on the mother’s abdominal surface. Usually, FPCG includes two major sounds for each fetal cardiac cycle: S1, produced by the sudden closure of mitral and tricuspid valves, and S2 produced by the closure of aortic and pulmonary valves. The aim of the present study was to propose AdvFPCG-Delineator for automatic fetal S1 and S2 identification and to demonstrate its reliability in different clinical conditions. The method consists of a wavelet-based filtering procedure followed by the computation of the scalogram, from which S1 and S2 were identified using a threshold-based algorithm. AdvFPCG-Delineator was tested on the “Simulated Fetal PCGs database” (37 FPCG signals) and on the experimental “Shiraz University fetal heart sounds database” (119 FPCG signals), both available at PhysioNet ( https://physionet.org ). Manual S1 and S2 annotations and simultaneously acquired cardiotocographic recordings were used to compute reference fetal heart rate (FHR) for the simulated and experimental databases, respectively. No statistically significant difference was observed between estimated vs reference FHR (140 bpm vs 140 bpm, respectively) for the simulated database, for which AdvFPCG-Delineator was also able to track beat-to-beat variability (correlation over 92%). Additionally, no statistically significant difference was observed between estimated vs reference FHR (141 bpm vs 140 bpm, respectively) for the experimental database, even when stratifying by clinical conditions (maternal age, gestational age, etc.). In conclusion, AdvFPCG-Delineator proved to be a reliable method to automatically identify S1 and S2 from fetal phonocardiograms.

Fetal phonocardiography (FPCG) is a non-invasive electronic recording of the acoustic cardiac signals. Unfortunately, FPCG is hidden by high-amplitude noise which makes detection of FPCG waveforms challenging. Aim of the study is to propose PCG-Delineator as an algorithm for automatic detection of the first and second heart sound (S1 and S2, respectively) from FPCG. To this aim, 37 simulated FPCG tracings (Physionet) are filtered by a wavelet-based procedure (4th order Coiflets mother wavelet with 7 decomposition levels) to erase noise. Successively, S1 and S2 are detected. S1 detection procedure is threshold-based (threshold=30% of the filtered FPCG signal maximum amplitude), under the condition that 40ms separate two consecutive S1 sounds. S2 detection procedure is also threshold-based, but under the conditions that S2 has to fall 100ms after preceding S1 and 200ms before successive S1, and that S2 has to have an amplitude lower than 80% that of preceding S1. Sensitivity (SE) and positive predictive values (PPV) were computed. Results indicate that PCG-Delineator was able to reduce noise (our SNR: from −1.1÷7.4dB to 12.9÷17.9dB; P

A heart affected by atrial fibrillation (AF) presents atrial cells that depolarize in many sites, generating a chaotic electrical activity. On the electrocardiogram (ECG), this activity reflects in the appearance of fibrillatory (F) waves, consisting of low-amplitude oscillations at 4–10 Hz. Aim of the present study is to propose an automatic AF identification method based on F-wave frequency analysis in 10 s ECGs. To this aim, 10 s ECG from 90 healthy subjects (HSs) and 50 AF patients (AFPs) were considered. ECGs were processed by the segmented beat modulation method to reduce components in the F-wave band. Then, the power spectral density (PSD) was computed and the F-wave frequency ratio (FWFR), defined as the ratio between the spectral area in the F-wave frequency band and the total spectral area, was computed. FWFR ability to discriminate AFPs from HSs was evaluated by analyzing the area under the curve (AUC) of the receiver operating characteristic, and by computation of sensitivity, specificity and accuracy. FWFR values were higher in AFPs than in HSs (p

T-wave alternans (TWA) is an every-other-beat fluctuation of the T-wave amplitude, often at microvolt (invisible) levels. It is recognized as an important risk index of severe ventricular arrhythmias, leading sometimes to sudden cardiac arrest. Many algorithms for automatic detection and quantification of TWA have been proposed; when applied to the same electrocardiogram (ECG), they may provide a different TWA quantification, making interpretation of differences difficult. Aim of this work is to propose TWA Simulator as a useful tool to validate and compare TWA identification methods. TWA Simulator is a user-friendly MATLAB graphical user interface (GUI) able to generate, model, visualize and store simulated ECG (SECG) affected by TWA of known morphology and amplitude. SECG is constructed by a N-fold repetition of a template, constituted by a real and clean ECG beat. Both number of beats and RR inter-beat variability can be set by the user. Both direct and inverted TWA can be simulated. Direct TWA is simulated by adding a waveform (among four possibility) to every other T wave; inverted TWA is simulated by changing T-wave polarity in every-other SECG beat. Availability of TWA Simulator would allow efficient validation and comparison of automatic TWA identification methods by helping interpretation of results.

Respiration rate and variability are indicators of health-condition changes. In chronic disease management, it is becoming increasingly desirable to use wearable devices in order to minimize invasiveness and maximize comfort. However, not all wearable devices integrate sensors for direct acquisition of respiratory (DAR) signal. In these cases, the breathing extraction can be done through indirect methods, typically from the electrocardiogram (ECG). The aim of the present study is to propose a single-ECG-lead procedure based on the Segmented-Beat Modulation Method (SBMM) as a suitable tool for ECG-derived respiratory (EDR) signal estimation and respiration frequency (RF) identification. Clinical data consisted of combined measurements of two-lead (I and II) ECG and DAR signals from 20 healthy subjects ('CEBS' database by Physionet). Each respiration-affected ECG lead was submitted to a specifically designed SBMMbased procedure for EDR estimation by ECG subtraction. RF from EDR and DAR were identified as the frequency at which the Fourier spectrum has a maximum in the 0.07-1.00 Hz frequency range. Results indicated that mean RF values over the population from EDR signals ($0.27 \pm 0.09$ Hz and $0.27 \pm 0.09$ Hz from leads I and II, respectively) were not significantly different from that from DAR ($0.28 \pm 0.09$ Hz). Moreover, differences in RF identification ($0.01 \pm 0.03$ Hz and $0.00 \pm 0.02$ Hz from leads I and II, respectively) were, on average not significantly different from 0. Thus, SBMM-based procedure is robust and accurate for EDR estimation and RF identification.

Fetal T-wave alternans (TWA) is a still littleknown marker for severe fetus-heart instabilities and may be related to some currently unjustified fetal deaths. Automatically detecting TWA on direct fetal electrocardiograms (DFECG) means possibility of providing fetuses the right treatment during delivery. Instead, automatically identifying TWA on indirect fetal electrocardiograms (IFECG) means possibility of providing fetuses the right treatment even during pregnancy, when taking actions for outcome improvement is still possible. Moreover, TWA identification from IFECG is noninvasive, and thus safe for both fetuses and mothers. The aim of this work was testing the heart-rate adaptive match filter (HRAMF) for automatic TWA identification in IFECG and comparing HRAMF performance in IFECG against DFECG. To this aim, simultaneously recorded DFECG and IFECG tracings from 5 healthy fetuses were used ("Abdominal and Direct Fetal Electrocardiogram Database" from Physionet). TWA measurements (frequency, mean amplitude, maximum amplitude, and amplitude standard deviation) in IFECG (1.09±0.04 Hz, 11±5 μV, 21±12 μV and 7±3 μV) were of the same order of magnitude of those in DFECG (1.07±0.02 Hz, 9±2 μV, 30±11 μV and 6±2 μV). Moreover, a direct correlation (ñ) was found between maximum TWA and fetal heart rate (IFECG: ρ=0.999; P=0.022; DEFEG: ρ=0.642; P=0.243). Thus, HRAMF was able to detect TWA from IFECG as well as from DFECG.

Cardiotocography (CTG) is the most commonly used test for establishing the good health of the fetus during pregnancy and labor. CTG consists in the recording of fetal heart rate (FHR; bpm) and maternal uterine contractions (UC; mmHg). FHR is characterized by baseline, baseline variability, tachycardia, bradycardia, acceleration and decelerations. Instead, UC signal is characterized by presence of contractions and contractions period. Such parameters are usually evaluated by visual inspection. However, visual analysis of CTG recordings has a well-demonstrated poor reproducibility, due to the complexity of physiological phenomena affecting fetal heart rhythm and being related to clinician's experience. Computerized tools in support of clinicians represents a possible solution for improving correctness in CTG interpretation. This paper proposes CTG Analyzer as a graphical tool for automatic and objective analysis of CTG tracings. CTG Analyzer was developed under MATLAB®; it is a very intuitive and user friendly graphical user interface. FHR time series and UC signal are represented one under the other, on a grid with reference lines, as usually done for CTG reports printed on paper. Colors help identification of FHR and UC features. Automatic analysis is based on some unchangeable features definitions provided by the FIGO guidelines, and other arbitrary settings whose default values can be changed by the user. Eventually, CTG Analyzer provides a report file listing all the quantitative results of the analysis. Thus, CTG Analyzer represents a potentially useful graphical tool for automatic and objective analysis of CTG tracings.

Sleep apnea (SA) is linked to cardiovascular complications and to an increased risk of sudden cardiac death. Microvolt T-wave alternans (TWA) is a noninvasive electrocardiographic (ECG) index of cardiovascular risk; its rate of occurrence in SA patients remains unknown. Thus, this study investigated the occurrence of TWA in SA patients during night. To this aim, overnight ECG recordings of 16 SA patients were analyzed for TWA identification by means of our heart rate adaptive match filter. Results indicate that overnight TWA was characterized by a low mean amplitude (mean TWA: 6±3 μV). However, higher-amplitude transient TWA episodes (max TWA: 29±21 μV) occurred overnight, sometimes when patients were awake (max TWA: 33±18 μV; 56% of cases) and sometimes when patients were sleeping (max TWA: 24±23 μV; 44% of cases with 13%, 19%, 6% and 6% during sleep stage 1, 2, 3 and 4, respectively). In only 3 subjects (19%) TWA peaks occurred during an SA episode: during obstructive apnea with arousal in two cases (max TWA of 7 μV and 17 μV, during stages 1 and 2, respectively) and during hypoapnea with arousal in one case (max TWA of 6 μV while awake). Thus, SA patients show significant transient overnight TWA episodes, not necessarily occurring during a SA episode.

Very little is known about the incidence and etiology of fetal T-wave alternans (TWA), an electrophysiologic phenomenon potentially associated to fetal suboptimal outcomes. Thus, availability of automatic methods for quantification of TWA from digital electrocardiograms (ECG) is desirable, since TWA occurrence might indicate the need of taking actions before or during delivery. The heart-rate adaptive match filter (HRAMF) is a well-established method to identify TWA in adult ECG. Aim of the present study was to investigate the possibility of using HRAMF to identify and quantify TWA also in direct fetal ECG (DFECG) recordings. To this aim, HRAMF was applied to 5 min-long DFECG acquired during delivery ("Abdominal and Direct Fetal Electrocardiogram Database" by Physionet) of five healthy fetuses. Significant levels of TWA were measured in all DFECG. Specifically, on average, TWA was quite high in amplitude (9±2 μV) and variable in time, as indicated by values of standard deviation (6±2 μV) and maximum (28±10 μV) of TWA amplitude. Eventually, a positive correlation (ρ=0.68) was observed between maximum TWA and fetal heart rate, even though the limited number of recordings makes this result preliminary. In conclusion, HRAMF proved to be a suitable tool to automatically identify TWA from DFECG.

Fetal phonocardiography (fPCG) is a clinical test to assess fetal wellbeing during pregnancy, labor and delivery. Still, its interpretation may be jeopardized by the presence of noise. Specifically, fPCG is typically corrupted by maternal heart and body organs sounds, fetal movements noise and surrounding environment noise. Thus, appropriate filtering procedures have to be applied in order to make fPCG clinically usable. Wavelet transformation (WT) has been proposed to filter fPCG; however, WT robustness to noise remains unknown. Thus, aim of the present work is to evaluate WT ability and robustness to denoise fPCG characterized by varying signal-to-noise ratios (SNR). To this aim a filtering procedure based on Coiflets mother wavelet (4th order, 7 levels of decomposition) was applied to 37 fPCG simulated tracings, all available in the Simulated Fetal PCGs database by Physionet. Original SNR values ranged from −1.38 dB to 4.54 dB; after application of WT-filtering procedure to fPCG, SNR increased significantly, ranging from 12.95 dB to 17.94 dB (P

Phonocardiography (PCG) second heart sound represents aortic-pulmonary valves closure and beginning of isovolumetric relaxation of the ventricles. Electrocardiography (ECG) T wave represents electrical repolarization of the ventricles. Ventricular electrical repolarization is known to drive ventricular mechanical relaxation. Thus, the aim of the present study was to investigate whether, in normal conditions, second heart sound onset (S2on) matches in time T-wave offset (Toff) so that S2on may be used to identify Toff. To this aim, 99 couples of simultaneously recorded short (around 30 s PCG and ECG) signals relative to normal subjects (selected from PhysioNet/CinC Challenge 2016: Training Set A) were analyzed. S2on was identified by application of our newly developed threshold-based algorithm to the median beat of the PCG envelope. Instead, Toff was identified by application of the Laguna and Thakor algorithm to the median ECG beat. Median time-distance (St) between S2on and Toff was 5 ms (P=0.007). Thus, in normal conditions, S2on and Toff differ on average of 5 ms, whose meaning remain to be defined. Still, 5 ms is included in the Toff identification variability (of the order of tens ms) due to different Toff identification methods and electrocardiographic leads. Consequently, in normal condition, S2on may be used to estimate Toff.

Proposed algorithms for P-wave identification and segmentation usually search for it within a window just before the R peak, thus hypothesizing the presence of at most one P wave, as it is in a normal electrocardiographic (ECG) tracings. In presence of abnormal atrial depolarization, however, there might be no P waves (as in atrial fibrillation) or multiple P waves (as in second- or third-degree atrioventricular blocks). Thus, this study proposes a new Adaptive Threshold Identification Algorithm (AThrIA) for ECG P-waves whose most innovative feature is to look for P waves all along the heartbeat, potentially allowing multiple P-waves identification. AThrIA ability to identify and segment (finding onset, maximum and offset) P waves was tested in simulated and experimental ECG tracings with no P waves, one P wave and two P waves, respectively. All P waves involved in the study were annotated. Results indicate that AThrIA correctly identified all P waves (no false-negative or false-positive detections). Segmentation errors were 0 ms for the simulated ECG tracings, and no more than 10 ms for the experimental tracings. Thus, AThrIA represents a promising tool for P-wave identification and segmentation in both physiological (one P wave) and pathological (none or multiple P waves) conditions.

Myocardial infarction (MI) is a major risk factor for heart failure (HF). The ECG is known to change during the acute and the healing phases of MI, and it stabilizes in the chronic phase. We expect that further ECG changes in the chronic period actually signify a worsening clinical condition / emergence of HF. One major characteristic that signifies an ECG change is the spatial QRS-T angle (SA). It is generally believed that a worsening ECG is accompanied by an enlargement of SA, but we have seen that some patients who developed HF after MI showed a decrease of SA. In the current study we aim to demonstrate that development of HF after MI is accompanied by a change in SA, but irrespective its sign. We retrospectively studied 81 control patients (67/14 male/female, mean±SD age 64±10 years) and 48 cases (38/10 male/female mean±SD age 60±12 years). Control patients had a healed MI and had, thereafter, two elective ECGs (baseline and follow-up) made >1 year apart. Case patients had a healed MI but presented later at our HF outpatient clinic with HF symptoms. Their baseline ECG was made at least 6 months post MI; the ECG made when presenting at the HF outpatient clinic was called follow-up ECG. In each ECG, we computed SA, and in each patient we computed the difference between the baseline and follow-up SAs. Finally we performed a ROC analysis on the signed and unsigned individual SA differences. ROC analysis revealed an area-under-the-curve (AUC) of 0.71 for signed SA differences, and 0.78 for unsigned SA differences. Both AUCs were significantly larger than 0.5, but the difference between these two curves did not reach statistical significance. In conclusion our study suggests that the best case-control separation can be attained by considering absolute SA changes, but a larger study is needed to demonstrate that SA changes irrespective the sign are performing significantly better than signed SA changes. The absolute change in SA is a promising ECG feature to detect emerging HF in post-MI patients.

Contactless detection is one of the new frontiers of technological innovation in the field of healthcare, enabling unobtrusive measurements of biomedical parameters. Compared to conventional methods for Heart Rate (HR) detection that employ expensive and/or uncomfortable devices, such as the Electrocardiograph (ECG) or pulse oximeter, contactless HR detection offers fast and continuous monitoring of heart activities and provides support for clinical analysis without the need for the user to wear a device. This paper presents a validation study for a contactless HR estimation method exploiting RGB (Red, Green, Blue) data from a Microsoft Kinect v2 device. This method, based on Eulerian Video Magnification (EVM), Photoplethysmography (PPG) and Videoplethysmography (VPG), can achieve performance comparable to classical approaches exploiting wearable systems, under specific test conditions. The output given by a Holter, which represents the gold-standard device used in the test for ECG extraction, is considered as the ground-truth, while a comparison with a commercial smartwatch is also included. The validation process is conducted with two modalities that differ for the availability of a priori knowledge about the subjects' normal HR. The two test modalities provide different results. In particular, the HR estimation differs from the ground-truth by 2% when the knowledge about the subject's lifestyle and his/her HR is considered and by 3.4% if no information about the person is taken into account.

Cardiotocography (CTG) is the most common non-invasive diagnostic technique to evaluate fetal well-being. It consists in the recording of fetal heart rate (FHR; bpm) and maternal uterine contractions. Among the main parameters characterizing FHR, baseline (BL) is fundamental to determine fetal hypoxia and distress. In computerized applications, BL is typically computed as mean FHR±ΔFHR, with ΔFHR=8 bpm or ΔFHR=10 bpm, both values being experimentally fixed. In this context, the present work aims: to propose a statistical procedure for ΔFHR assessment; to quantitatively determine ΔFHR value by applying such procedure to clinical data; and to compare the statistically-determined ΔFHR value against the experimentally-determined ΔFHR values. To these aims, the 552 recordings of the “CTU-UHB intrapartum CTG database” from Physionet were submitted to an automatic procedure, which consisted in a FHR preprocessing phase and a statistical BL assessment. During preprocessing, FHR time series were divided into 20-min sliding windows, in which missing data were removed by linear interpolation. Only windows with a correction rate lower than 10% were further processed for BL assessment, according to which ΔFHR was computed as FHR standard deviation. Total number of accepted windows was 1192 (38.5%) over 383 recordings (69.4%) with at least an accepted window. Statistically-determined ΔFHR value was 9.7 bpm. Such value was statistically different from 8 bpm (P

Electrocardiography (ECG) and surface electromyography (SEMG) are two non-invasive tests to evaluate cardiac and muscular functionality, respectively. They are both acquired by placing electrodes on the body surface so they become one the interference of the other. Typically, linear filters are used for ECG and SEMG separation: high-pass filters with cutoff at 20 Hz to attenuate ECG interference in SEMG, and low-pass filters with cut-off at 50 Hz to attenuate SEMG interference in ECG. In spite of that, linear filtering is not adequate due to the presence of a 20-50 Hz frequency-band in which the two signal spectra overlap. The aim of the present study was to evaluate the ability of the Segmented-Beat Modulation Method (SBMM) for ECG and SEMG separation and by accurately maintaining signals characteristics. SBMM is a template-based technique for ECG denoising: under the hypothesis of ECG and SEMG linearly superimposed, it first provides an ECG estimation, and then an SEMG estimation by subtraction. In order to test the method under several conditions, SBMM was applied to simulated as well as clinical recordings with superimposed ECG and SEMG. SBMM was able to accurately estimate both ECG and SEMG in all cases. Indeed, ECG and SEMG were estimated by maintain their features such as amplitude (estimation errors

The Zephyr BioHarness 3.0 (BH3) is a popular wearable system specifically designed for training optimization of professional athletes. BH3 provides the electrocardiogram (ECG BH3) and the heart-rate signal (HRSBH3). Aim of this study is to evaluate the reliability of HRSBH3 to assess its clinical applicability to the general population for cardiac-risk evaluations. Data were acquired from 10 healthy subjects (age: 34±17 years) during a 5-minutes rest. Since the tachogram represents the standard signal for studying the heart rate (HR) and its variability, ECG BH3 was elaborated in order to get the tachogram (HRSTG). HRSBH3 and HRSTG were compared in terms of mean HR (MHR, bpm), HR standard deviation (HRSD, bpm) and HRSD error (bpm). HRSBH3 and HRSTG provided comparable MHR (73.07±15.53 bpm vs 72.86±15.57 bpm, respectively) while HRSD by HRSBH3 was significantly lower than HRSD by HRS TG (4.51 ±2.29 bpm vs 5.63±2.99 bpm, respectively; P=0.0043). HRSD error was significantly greater than zero (0.20–3.00 bpm; P=0.0043); moreover, it was strongly correlated to HRSD by HRS TG (p=0.82, P=0.0036). Thus, HRS BH3 is appropriate only for sport applications based on MHR estimations, but not to clinical evaluations based on HRV measurements.